1.765
price down icon0.28%   -0.005
 
loading
Schlusskurs vom Vortag:
$1.77
Offen:
$1.78
24-Stunden-Volumen:
200.91K
Relative Volume:
1.10
Marktkapitalisierung:
$78.57M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-28.54M
KGV:
-2.7578
EPS:
-0.64
Netto-Cashflow:
$-22.72M
1W Leistung:
-0.28%
1M Leistung:
+13.14%
6M Leistung:
-67.85%
1J Leistung:
-70.97%
1-Tages-Spanne:
Value
$1.75
$1.85
1-Wochen-Bereich:
Value
$1.75
$1.905
52-Wochen-Spanne:
Value
$1.40
$7.88

Essa Pharma Inc Stock (EPIX) Company Profile

Name
Firmenname
Essa Pharma Inc
Name
Telefon
(778) 331-0962
Name
Adresse
SUITE 720, VANCOUVER, BC
Name
Mitarbeiter
35
Name
Twitter
@essapharma
Name
Nächster Verdiensttermin
2025-02-11
Name
Neueste SEC-Einreichungen
Name
EPIX's Discussions on Twitter

Vergleichen Sie EPIX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
EPIX
Essa Pharma Inc
1.765 78.57M 0 -28.54M -22.72M -0.64
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.63 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
606.78 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.03 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
253.60 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
250.19 24.70B 3.81B -644.79M -669.77M -6.24

Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-04 Herabstufung Jefferies Buy → Hold
2024-11-04 Herabstufung Oppenheimer Outperform → Perform
2024-11-04 Herabstufung Piper Sandler Overweight → Neutral
2023-06-26 Fortgesetzt Oppenheimer Outperform
2021-03-04 Eingeleitet Piper Sandler Overweight
2021-01-11 Bestätigt H.C. Wainwright Buy
2020-11-02 Eingeleitet Jefferies Buy
2019-10-25 Eingeleitet Oppenheimer Outperform
Alle ansehen

Essa Pharma Inc Aktie (EPIX) Neueste Nachrichten

pulisher
Apr 26, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 22, 2025

Investors who hold shares of ESSA Pharma Inc. (NASDAQ: EPIX) Long - openPR.com

Apr 22, 2025
pulisher
Apr 21, 2025

Alis Biosciences Launches To Free Cash From Stalled-Out Biotechs - insights.citeline.com

Apr 21, 2025
pulisher
Apr 17, 2025

Finance Watch: Investors Push ESSA Pharma, Elevation Oncology To Wind Down - insights.citeline.com

Apr 17, 2025
pulisher
Apr 15, 2025

ESSA Pharma Inc. (NASDAQ:EPIX): Are Analysts Optimistic? - simplywall.st

Apr 15, 2025
pulisher
Apr 01, 2025

We're Not Very Worried About ESSA Pharma's (NASDAQ:EPIX) Cash Burn Rate - Yahoo Finance

Apr 01, 2025
pulisher
Mar 25, 2025

The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire

Mar 25, 2025
pulisher
Mar 25, 2025

ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pha - GuruFocus

Mar 25, 2025
pulisher
Mar 25, 2025

ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire

Mar 25, 2025
pulisher
Mar 25, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - Markets Insider

Mar 25, 2025
pulisher
Mar 25, 2025

EPIX Deadline Today: Rosen Law Firm Urges ESSA Pharma Inc. (NASDAQ: EPIX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire

Mar 25, 2025
pulisher
Mar 24, 2025

ESSA Pharma Inc. Investors: Please contact the Portnoy Law - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - Business Wire

Mar 24, 2025
pulisher
Mar 24, 2025

The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pen - GuruFocus

Mar 24, 2025
pulisher
Mar 24, 2025

ESSA Pharma Inc. Securities Fraud Class Action Lawsuit - GlobeNewswire

Mar 24, 2025
pulisher
Mar 23, 2025

EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Mar 23, 2025
pulisher
Mar 23, 2025

Shareholders that lost money on ESSA Pharma Inc.(EPIX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

Mar 23, 2025
pulisher
Mar 23, 2025

EPIX IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, - GlobeNewswire

Mar 23, 2025
pulisher
Mar 23, 2025

EPIX IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class ActionEPIX - TradingView

Mar 23, 2025
pulisher
Mar 23, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - GlobeNewswire

Mar 23, 2025
pulisher
Mar 23, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - GlobeNewswire Inc.

Mar 23, 2025
pulisher
Mar 23, 2025

ESSA Pharma Inc. Faces Securities Fraud Class Action Over Alleged Investor Misleading Statements - Apna Kal

Mar 23, 2025
pulisher
Mar 22, 2025

Investors in ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX - ACCESS Newswire

Mar 22, 2025
pulisher
Mar 21, 2025

Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - Longview News-Journal

Mar 21, 2025
pulisher
Mar 20, 2025

ESSA Pharma Inc. (NASDAQ: EPIX) Investor Alert: Deadline in Lawsuit on March 25, 2025 - openPR

Mar 20, 2025
pulisher
Mar 20, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ESSA, Cardlytics, Novo Nordisk, and Crocs and Encourages Investors to Contact the Firm - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

EPIX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 25 Deadline in Securities Class ActionEPIX - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

The Gross Law Firm Reminds ESSA Pharma Inc. Investors of - GlobeNewswire

Mar 20, 2025
pulisher
Mar 20, 2025

The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – EPIX - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

EPIX Lawsuit Alert! Class Action Lawsuit Against ESSA Pharma, Inc. - TipRanks

Mar 20, 2025
pulisher
Mar 19, 2025

EPIX Investors Have Final Opportunity Approaching to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar

Mar 19, 2025
pulisher
Mar 18, 2025

EPIX Deadline: EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit - PR Newswire

Mar 18, 2025
pulisher
Mar 18, 2025

Levi & Korsinsky Notifies Shareholders of ESSA Pharma - GlobeNewswire

Mar 18, 2025
pulisher
Mar 17, 2025

ESSA Pharma Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX - ACCESS Newswire

Mar 17, 2025
pulisher
Mar 17, 2025

EPIX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - StreetInsider.com

Mar 17, 2025
pulisher
Mar 17, 2025

2025-03-17 | INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma | NDAQ:EPIX | Press Release - Stockhouse Publishing

Mar 17, 2025
pulisher
Mar 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ESSA Pharma Inc. and Certain OfficersEPIX - PR Newswire

Mar 17, 2025
pulisher
Mar 17, 2025

ESSA Pharma Inc. Class Action: The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire

Mar 17, 2025
pulisher
Mar 16, 2025

2025-03-16 | ESSA Pharma Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing

Mar 16, 2025
pulisher
Mar 16, 2025

EPIX Stockholders Have Opportunity to Lead ESSA Pharma Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - Markets Insider

Mar 16, 2025
pulisher
Mar 15, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire

Mar 15, 2025
pulisher
Mar 14, 2025

Levi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineEPIX - Stockhouse Publishing

Mar 14, 2025
pulisher
Mar 14, 2025

EPIX FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages - GlobeNewswire

Mar 14, 2025
pulisher
Mar 14, 2025

EPIX FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - GlobeNewswire Inc.

Mar 14, 2025
pulisher
Mar 14, 2025

EPIX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ESSA Pharma Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider

Mar 14, 2025
pulisher
Mar 14, 2025

2025-03-14 | Investors who lost money on ESSA Pharma Inc.(EPIX) should contact Levi & Korsinsky about pending Class ActionEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing

Mar 14, 2025
pulisher
Mar 14, 2025

EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar

Mar 14, 2025

Finanzdaten der Essa Pharma Inc-Aktie (EPIX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.65
price up icon 0.63%
$70.47
price up icon 1.28%
$32.49
price up icon 0.64%
$23.90
price up icon 1.85%
$108.35
price up icon 3.89%
biotechnology ONC
$247.87
price up icon 1.21%
Kapitalisierung:     |  Volumen (24h):